To mirror the conditions of the SOS study where all the participants are affected by obesity, we decided to stratify the population according to BMI and found that elevated circulating adiponectin levels were associated with an increased risk of RA independently of leptin and resistin only in participants with overweight/obesity. The gene discussed is ADIPOQ; the disease is rheumatoid arthritis.